Protocolo de tratamiento empírico de la neumonía nosocomial y asociada a ventilador

• Díaz de Santiago, A. ^[1] ; Callejas Díaz, A. ^[1] ; Muñoz Serrano, A. ^[1]
  1. [1] Servicio de Medicina Interna. Hospital Universitario Puerta de Hierro. Majadahonda. Madrid. España Universidad Autónoma de Madrid. Madrid. España Instituto de Investigación Sanitaria Puerta de Hierro Segovia de Arana (IDIPHISA). Majadahonda. Madrid. España
• Localización: Medicine: Programa de Formación Médica Continuada Acreditado, ISSN 0304-5412, Serie 13, Nº. 51, 2022 (Ejemplar dedicado a: Enfermedades infecciosas (III)), págs. 3016-3018
• Idioma: español
• Títulos paralelos:
  • Protocol for the empirical treatment of hospital-acquired pneumonia and ventilator-associated pneumonia
• Texto completo no disponible (Saber más ...)
• Resumen

  • Hospital-acquired pneumonia (HAP) is a lower respiratory tract infection that is absent at the time of admission which develops after more than 48 hours since the hospital admission. Ventilator-associated pneumonia (VAP) is a subgroup of HAP that is very prevalent in intensive care units (ICU). To the extent it is possible, the pertinent microbiological specimens must be collected before starting antimicrobial therapy, but treatment should not be delayed in the event of clinical suspicion. When choosing empirical treatment, we must bear in mind the local microbiology of the hospital and of each hospitalization/intensive care unit, suspicion of multidrug-resistant germs, and severity criteria. The treatment schedules used in the latest national and international guidelines are studied. Currently, indications of seven days of treatment are preferred if clinical progress is favorable.